A two-microRNA signature predicts the progression of male thyroid cancer
In various cancers, microRNAs (miRNAs) are abnormally expressed, including thyroid cancer (TC). In recent years, the incidence of TC has increased annually around the world. Compared with female patients, male TC patients are more likely to have a postoperative recurrence and lymph node metastasis,...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
De Gruyter
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/68a76a11c3344b80a1eaf7a36400d232 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:68a76a11c3344b80a1eaf7a36400d232 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:68a76a11c3344b80a1eaf7a36400d2322021-12-05T14:10:41ZA two-microRNA signature predicts the progression of male thyroid cancer2391-541210.1515/biol-2021-0099https://doaj.org/article/68a76a11c3344b80a1eaf7a36400d2322021-09-01T00:00:00Zhttps://doi.org/10.1515/biol-2021-0099https://doaj.org/toc/2391-5412In various cancers, microRNAs (miRNAs) are abnormally expressed, including thyroid cancer (TC). In recent years, the incidence of TC has increased annually around the world. Compared with female patients, male TC patients are more likely to have a postoperative recurrence and lymph node metastasis, and hence need second treatments. However, the molecular biological processes underlying this phenomenon are not understood. Therefore, we collected data on miRNA expression and clinical information of male TC patients from The Cancer Genome Atlas (TCGA) database. Differentially expressed miRNAs were identified between male TC tissues and matched normal tissues. The Kaplan–Meier method, univariate and multivariate Cox regressions, and receiver operating characteristic curve analyses were performed to assess the association between miRNAs and the disease-free survival of male TC patients. Gene Ontology (GO) and the Kyoto Encyclopaedia of Gene and Genome (KEGG) enrichment analyses were then used to explore the function of miRNA target genes. Furthermore, we evaluated the ability of the miRNA biomarker to predict survival in female TC patients. As a result, a total of 118 differentially expressed miRNAs were identified, including 25 upregulated and 93 downregulated miRNAs. Among them, miR-451a and miR-16-1-3p were confirmed to be independent prognostic factors for the disease-free survival rate. The target genes of miR-451a and miR-16-1-3p were identified, and functional analysis showed that these genes were enriched in 25 Go and KEGG accessions, including cell signal transduction, motor adhesion, phagocytosis, regulation of transcription, cell proliferation, angiogenesis, etc. Neither miR-451a and miR-16-1-3p, nor a prediction model based on both miRNAs effectively predicted survival in female TC patients. In conclusion, both miR-451a and miR-16-1-3p may play important roles in the processes of male TC. The two-miRNA signature involving miR-1258 and miR-193a may serve as a novel prognostic biomarker for male TC patients.Liu BingyangShi HaihongQiu WeigangWu XinquanLi LiqiongWu WenyiDe Gruyterarticlemale thyroid cancermicrorna signaturetumour progressionmir-451amir-16-1-3pBiology (General)QH301-705.5ENOpen Life Sciences, Vol 16, Iss 1, Pp 981-991 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
male thyroid cancer microrna signature tumour progression mir-451a mir-16-1-3p Biology (General) QH301-705.5 |
spellingShingle |
male thyroid cancer microrna signature tumour progression mir-451a mir-16-1-3p Biology (General) QH301-705.5 Liu Bingyang Shi Haihong Qiu Weigang Wu Xinquan Li Liqiong Wu Wenyi A two-microRNA signature predicts the progression of male thyroid cancer |
description |
In various cancers, microRNAs (miRNAs) are abnormally expressed, including thyroid cancer (TC). In recent years, the incidence of TC has increased annually around the world. Compared with female patients, male TC patients are more likely to have a postoperative recurrence and lymph node metastasis, and hence need second treatments. However, the molecular biological processes underlying this phenomenon are not understood. Therefore, we collected data on miRNA expression and clinical information of male TC patients from The Cancer Genome Atlas (TCGA) database. Differentially expressed miRNAs were identified between male TC tissues and matched normal tissues. The Kaplan–Meier method, univariate and multivariate Cox regressions, and receiver operating characteristic curve analyses were performed to assess the association between miRNAs and the disease-free survival of male TC patients. Gene Ontology (GO) and the Kyoto Encyclopaedia of Gene and Genome (KEGG) enrichment analyses were then used to explore the function of miRNA target genes. Furthermore, we evaluated the ability of the miRNA biomarker to predict survival in female TC patients. As a result, a total of 118 differentially expressed miRNAs were identified, including 25 upregulated and 93 downregulated miRNAs. Among them, miR-451a and miR-16-1-3p were confirmed to be independent prognostic factors for the disease-free survival rate. The target genes of miR-451a and miR-16-1-3p were identified, and functional analysis showed that these genes were enriched in 25 Go and KEGG accessions, including cell signal transduction, motor adhesion, phagocytosis, regulation of transcription, cell proliferation, angiogenesis, etc. Neither miR-451a and miR-16-1-3p, nor a prediction model based on both miRNAs effectively predicted survival in female TC patients. In conclusion, both miR-451a and miR-16-1-3p may play important roles in the processes of male TC. The two-miRNA signature involving miR-1258 and miR-193a may serve as a novel prognostic biomarker for male TC patients. |
format |
article |
author |
Liu Bingyang Shi Haihong Qiu Weigang Wu Xinquan Li Liqiong Wu Wenyi |
author_facet |
Liu Bingyang Shi Haihong Qiu Weigang Wu Xinquan Li Liqiong Wu Wenyi |
author_sort |
Liu Bingyang |
title |
A two-microRNA signature predicts the progression of male thyroid cancer |
title_short |
A two-microRNA signature predicts the progression of male thyroid cancer |
title_full |
A two-microRNA signature predicts the progression of male thyroid cancer |
title_fullStr |
A two-microRNA signature predicts the progression of male thyroid cancer |
title_full_unstemmed |
A two-microRNA signature predicts the progression of male thyroid cancer |
title_sort |
two-microrna signature predicts the progression of male thyroid cancer |
publisher |
De Gruyter |
publishDate |
2021 |
url |
https://doaj.org/article/68a76a11c3344b80a1eaf7a36400d232 |
work_keys_str_mv |
AT liubingyang atwomicrornasignaturepredictstheprogressionofmalethyroidcancer AT shihaihong atwomicrornasignaturepredictstheprogressionofmalethyroidcancer AT qiuweigang atwomicrornasignaturepredictstheprogressionofmalethyroidcancer AT wuxinquan atwomicrornasignaturepredictstheprogressionofmalethyroidcancer AT liliqiong atwomicrornasignaturepredictstheprogressionofmalethyroidcancer AT wuwenyi atwomicrornasignaturepredictstheprogressionofmalethyroidcancer AT liubingyang twomicrornasignaturepredictstheprogressionofmalethyroidcancer AT shihaihong twomicrornasignaturepredictstheprogressionofmalethyroidcancer AT qiuweigang twomicrornasignaturepredictstheprogressionofmalethyroidcancer AT wuxinquan twomicrornasignaturepredictstheprogressionofmalethyroidcancer AT liliqiong twomicrornasignaturepredictstheprogressionofmalethyroidcancer AT wuwenyi twomicrornasignaturepredictstheprogressionofmalethyroidcancer |
_version_ |
1718371843338928128 |